HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erica B Lee Selected Research

Ankylosing Spondylitis

6/2020Risk of herpes zoster with IL-17 inhibitor therapy for psoriasis and other inflammatory conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erica B Lee Research Topics

Disease

30Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022 - 03/2018
3Atopic Dermatitis (Atopic Eczema)
12/2023 - 03/2019
2Dermatitis
12/2023 - 01/2021
2Inflammation (Inflammations)
01/2019 - 01/2019
1Drug-Related Side Effects and Adverse Reactions
12/2023
1Muscular Atrophy (Muscle Atrophy)
07/2023
1Systemic Mastocytosis
09/2022
1Hypersensitivity (Allergy)
09/2022
1Annular Erythema
09/2022
1Contact Dermatitis (Eczema, Contact)
01/2021
1Skin Neoplasms (Skin Cancer)
01/2021
1Allergic Contact Dermatitis
01/2021
1COVID-19
01/2021
1Neoplasms (Cancer)
01/2021
1Invasive Fungal Infections
10/2020
1Mycoses (Diseases, Fungus)
10/2020
1Herpes Zoster
06/2020
1Asthma (Bronchial Asthma)
06/2020
1Psoriatic Arthritis
06/2020
1Ankylosing Spondylitis
06/2020
1Infections
06/2020
1Rheumatoid Arthritis
06/2020
1Pemphigus (Pemphigus Vulgaris)
01/2020
1Cerebral Toxoplasmosis
01/2020
1Pain (Aches)
08/2019
1Lentigo (Lentiginosis)
01/2019
1Skin Manifestations
01/2019
1Tuberculosis (Tuberculoses)
11/2018
1Latent Tuberculosis
11/2018

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
08/2022 - 01/2019
4Interleukin-17 (Interleukin 17)IBA
10/2020 - 01/2019
4Interleukin-23 (Interleukin 23)IBA
10/2020 - 01/2019
3secukinumabIBA
06/2020 - 01/2019
3ixekizumabIBA
06/2020 - 01/2019
3Tumor Necrosis Factor InhibitorsIBA
02/2020 - 09/2018
2dupilumabIBA
12/2023 - 02/2022
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2020 - 04/2020
2Biosimilar PharmaceuticalsIBA
08/2020 - 04/2020
2Etanercept (Enbrel)FDA Link
08/2020 - 11/2018
2Adalimumab (Humira)FDA Link
08/2020 - 11/2018
2brodalumabIBA
06/2020 - 03/2019
2guselkumabIBA
01/2020 - 01/2019
2apremilastIBA
10/2018 - 10/2018
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
12/2023
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2023
1Tryptases (Tryptase)IBA
09/2022
1AntigensIBA
09/2022
1AllergensIBA
01/2021
1Vitamin DFDA LinkGeneric
12/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2020
1Local Anti-Infective Agents (Antiseptics)IBA
12/2020
1Immunologic Factors (Immunomodulators)IBA
12/2020
1Interleukin InhibitorsIBA
10/2020
1Interleukin-12 (IL 12)IBA
10/2020
1Infliximab (Remicade)FDA Link
08/2020
1CT-P13IBA
08/2020
1Rituximab (Mabthera)FDA Link
01/2020
1Phosphodiesterase 4 InhibitorsIBA
03/2019
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
03/2019
1crisaboroleIBA
03/2019
1AntibodiesIBA
03/2019
1Calcitonin Gene-Related PeptideIBA
01/2019
1Substance PIBA
01/2019
1InterleukinsIBA
01/2019
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2019
1NeuropeptidesIBA
01/2019
1Nerve Growth Factor (NGF)IBA
01/2019
1tildrakizumabIBA
01/2019
1SteroidsIBA
07/2018
1Janus Kinase InhibitorsIBA
03/2018

Therapy/Procedure

14Therapeutics
12/2023 - 03/2018
3Biological Therapy
08/2020 - 03/2018
2Phototherapy (Light Therapy)
11/2020 - 01/2019
1Denervation
07/2023
1Transplantation
07/2023
1Personal Protective Equipment
01/2021
1Dermatologic Surgical Procedures
01/2021
1Mohs Surgery (Mohs' Micrographic Surgery)
01/2021
1Lasers (Laser)
11/2020
1Excimer Lasers
11/2020
1Contraindications
08/2019